NVCR insider transactions
NovoCure Limited (NVCR) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for NVCR
- Director Stafford Kristin was granted 11,610 units of Ordinary Shares, increasing direct ownership by 103% to 22,934 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Chief Executive Officer Leonard Frank X sold $614,635 worth of Ordinary Shares (34,273 units at $17.93), decreasing direct ownership by 7% to 459,520 units (SEC Form 4) (withholding tax)4 - NovoCure Ltd (0001645113) (Issuer)
- Director Leung Gabriel was granted 11,610 units of Ordinary Shares, increasing direct ownership by 13% to 101,109 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Director Ocean Allyson J was granted 11,610 units of Ordinary Shares, increasing direct ownership by 103% to 22,934 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Director Scannell Timothy J was granted 11,610 units of Ordinary Shares, increasing direct ownership by 81% to 25,898 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Director Hilleman Jeryl L was granted 11,610 units of Ordinary Shares, increasing direct ownership by 84% to 25,471 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Director Hung David was granted 11,610 units of Ordinary Shares, increasing direct ownership by 57% to 32,075 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Director Madden Martin J. was granted 11,610 units of Ordinary Shares, increasing direct ownership by 62% to 30,284 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Director Vernon W Anthony was granted 11,610 units of Ordinary Shares, increasing direct ownership by 6% to 209,267 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Director Leung Gabriel sold $46,445 worth of Ordinary Shares (2,945 units at $15.77), decreasing direct ownership by 3% to 89,499 units (SEC Form 4) to satisfy withholding tax4 - NovoCure Ltd (0001645113) (Issuer)
- Director Stafford Kristin sold $46,445 worth of Ordinary Shares (2,945 units at $15.77), decreasing direct ownership by 21% to 11,324 units (SEC Form 4) (withholding obligation)4 - NovoCure Ltd (0001645113) (Issuer)
- Director Ocean Allyson J sold $46,445 worth of Ordinary Shares (2,945 units at $15.77), decreasing direct ownership by 21% to 11,324 units (SEC Form 4) to cover withholding tax4 - NovoCure Ltd (0001645113) (Issuer)
- Director Scannell Timothy J sold $46,445 worth of Ordinary Shares (2,945 units at $15.77), decreasing direct ownership by 17% to 14,288 units (SEC Form 4) to satisfy withholding obligation4 - NovoCure Ltd (0001645113) (Issuer)
- Director Hilleman Jeryl L sold $46,445 worth of Ordinary Shares (2,945 units at $15.77), decreasing direct ownership by 18% to 13,861 units (SEC Form 4) (for withholding tax)4 - NovoCure Ltd (0001645113) (Issuer)
- Director Vernon W Anthony sold $46,445 worth of Ordinary Shares (2,945 units at $15.77), decreasing direct ownership by 1% to 197,657 units (SEC Form 4) to satisfy tax liability4 - NovoCure Ltd (0001645113) (Issuer)
- Director Hung David sold $46,445 worth of Ordinary Shares (2,945 units at $15.77), decreasing direct ownership by 13% to 20,465 units (SEC Form 4) (for withholding tax)4 - NovoCure Ltd (0001645113) (Issuer)
- Director Vernon W Anthony exercised 21,500 units of Ordinary Shares at a strike of $11.39, increasing direct ownership by 12% to 200,602 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Former Chief Medical Officer Leupin Nicolas sold $14,636 worth of Ordinary Shares (1,100 units at $13.31), decreasing direct ownership by 1% to 102,979 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Former Chief Executive Officer Cordova Ashley covered exercise/tax liability with 17,638 units of Ordinary Shares, decreasing direct ownership by 4% to 422,570 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- General Counsel Ben Arye Barak was granted 50,125 units of Ordinary Shares, increasing direct ownership by 26% to 242,453 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Chf Medical and Innovation Ofr Weinberg Uri was granted 50,125 units of Ordinary Shares and sold $85,314 worth of Ordinary Shares (6,412 units at $13.31), increasing direct ownership by 20% to 267,190 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Chief Financial Officer Brackmann Christoph was granted 55,137 units of Ordinary Shares and sold $85,314 worth of Ordinary Shares (6,412 units at $13.31), increasing direct ownership by 36% to 182,842 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Chief Executive Officer Leonard Frank X sold $74,603 worth of Ordinary Shares (5,607 units at $13.31) and was granted 150,000 units of Ordinary Shares, increasing direct ownership by 41% to 493,793 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Chief Operating Officer Paravasthu Mukund was granted 45,112 units of Ordinary Shares and sold $667,214 worth of Ordinary Shares (48,623 units at $13.72), decreasing direct ownership by 5% to 72,832 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Chief Human Resources Officer Puri Michal Nath was granted 40,100 units of Ordinary Shares and sold $14,636 worth of Ordinary Shares (1,100 units at $13.31), increasing direct ownership by 24% to 201,322 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Executive Chairman Doyle William F was granted 400,284 units of Ordinary Shares and sold $932,883 worth of Ordinary Shares (71,887 units at $12.98) (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Former Chief Executive Officer Cordova Ashley covered exercise/tax liability with 21,179 units of Ordinary Shares and was granted 23,818 units of Ordinary Shares, increasing direct ownership by 0.60% to 440,208 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Chief Human Resources Officer Puri Michal Nath sold $19,690 worth of Ordinary Shares (1,441 units at $13.66), decreasing direct ownership by 0.88% to 162,322 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Chief Executive Officer Leonard Frank X was granted 18,621 units of Ordinary Shares and sold $230,585 worth of Ordinary Shares (16,966 units at $13.59), increasing direct ownership by 0.48% to 349,400 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- General Counsel Ben Arye Barak was granted 17,755 units of Ordinary Shares, increasing direct ownership by 10% to 192,328 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Chf Medical and Innovation Ofr Weinberg Uri sold $146,863 worth of Ordinary Shares (10,733 units at $13.68) and was granted 12,992 units of Ordinary Shares, increasing direct ownership by 1% to 223,477 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Chief Operating Officer Paravasthu Mukund covered exercise/tax liability with 2,133 units of Ordinary Shares, decreasing direct ownership by 3% to 78,306 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Puri Michal Nath was granted 1 units of Ordinary Shares, increasing direct ownership by 0.00% to 163,763 units (SEC Form 5)5 - NovoCure Ltd (0001645113) (Issuer)
- Danziger Asaf was granted 1 units of Ordinary Shares, increasing direct ownership by 0.00% to 416,474 units (SEC Form 5)5 - NovoCure Ltd (0001645113) (Issuer)
- Ben Arye Barak was granted 108 units of Ordinary Shares, increasing direct ownership by 0.06% to 174,573 units (SEC Form 5)5 - NovoCure Ltd (0001645113) (Issuer)
- Chief Financial Officer Brackmann Christoph covered exercise/tax liability with 7,033 units of Ordinary Shares, decreasing direct ownership by 5% to 134,117 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Chief Operating Officer Paravasthu Mukund covered exercise/tax liability with 3,117 units of Ordinary Shares, decreasing direct ownership by 4% to 80,439 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- EVP, Pres., Novocure Oncology Leonard Frank X covered exercise/tax liability with 966 units of Ordinary Shares, decreasing direct ownership by 0.28% to 347,745 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Chief Human Resources Officer Puri Michal Nath covered exercise/tax liability with 752 units of Ordinary Shares, decreasing direct ownership by 0.46% to 163,762 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Chief Executive Officer Cordova Ashley bought $996,859 worth of Ordinary Shares (81,550 units at $12.22), increasing direct ownership by 23% to 437,569 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Chief Financial Officer Brackmann Christoph bought $231,800 worth of Ordinary Shares (20,000 units at $11.59), increasing direct ownership by 17% to 141,150 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Chief Human Resources Officer Puri Michal Nath was granted 833 units of Ordinary Shares, increasing direct ownership by 0.51% to 164,514 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Director Danziger Asaf was granted 833 units of Ordinary Shares, increasing direct ownership by 0.20% to 416,473 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- EVP, Pres., Novocure Oncology Leonard Frank X was granted 833 units of Ordinary Shares, increasing direct ownership by 0.24% to 348,711 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Chief Executive Officer Cordova Ashley was granted 833 units of Ordinary Shares, increasing direct ownership by 0.23% to 356,019 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- General Counsel Ben Arye Barak was granted 769 units of Ordinary Shares, increasing direct ownership by 0.44% to 174,465 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Director Leung Gabriel was granted 11,215 units of Ordinary Shares, increasing direct ownership by 14% to 92,444 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Director Stafford Kristin was granted 11,215 units of Ordinary Shares, increasing direct ownership by 367% to 14,269 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- SEC Form 4 filed by Director Madden Martin J.4 - NovoCure Ltd (0001645113) (Issuer)
- Director Hilleman Jeryl L was granted 11,215 units of Ordinary Shares, increasing direct ownership by 201% to 16,806 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Director Ocean Allyson J was granted 11,215 units of Ordinary Shares, increasing direct ownership by 367% to 14,269 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Director Scannell Timothy J was granted 11,215 units of Ordinary Shares, increasing direct ownership by 186% to 17,233 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Director Hung David was granted 11,215 units of Ordinary Shares, increasing direct ownership by 92% to 23,410 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Director Vernon W Anthony was granted 11,215 units of Ordinary Shares, increasing direct ownership by 7% to 179,102 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- EVP, Pres., Novocure Oncology Leonard Frank X was granted 179,426 units of Ordinary Shares, increasing direct ownership by 107% to 347,878 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Director Stafford Kristin sold $17,259 worth of Ordinary Shares (999 units at $17.28), decreasing direct ownership by 25% to 3,054 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Director Leung Gabriel sold $17,297 worth of Ordinary Shares (999 units at $17.31), decreasing direct ownership by 1% to 81,229 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Director Madden Martin J. sold $17,176 worth of Ordinary Shares (999 units at $17.19), decreasing direct ownership by 5% to 18,674 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Director Scannell Timothy J sold $17,299 worth of Ordinary Shares (999 units at $17.32), decreasing direct ownership by 14% to 6,018 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)
- Director Hilleman Jeryl L sold $17,247 worth of Ordinary Shares (999 units at $17.26), decreasing direct ownership by 15% to 5,591 units (SEC Form 4)4 - NovoCure Ltd (0001645113) (Issuer)